Peningkatan Jumlah Protein S100 pada Vitiligo setelah Terapi Narrowband-Ultraviolet B
Downloads
Birlea SA, Spritz RA, Norris DA. Vitiligo. Dalam: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Leffel DJ, editors. Fitzpatrick's Dermatology General Medicine. 8th Ed. New York: McGraw Hill Co. 2013. p.792-803.
Kutlubay Z, Karakus O, Engin B, Serdaroglu S. Vitiligo as autoimun disease. J Turk Acad Dermatol 2012;6(2):126r1.
Alikhan MD, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: A comprehensive overview. J Am Acad Dermatol 2011;65:473-91.
Hutomo S. Penelitian retrospektif penderita vitiligo di divisi kosmetik medik URJ kesehatan kulit dan kelamin RSUD Dr. Soetomo Surabaya periode 2009-2011. Penelitian Retrospektif. Surabaya. 2012.
Nybakken GE, Sargen M, Abraham R, Zhang PJ, Ming M, Xu X. MITF acurately highlight epidermal melanocytes in atypical intraepidermal melanocytic proliferations. Am J Dermatopathol 2013;35(1):25-9.
Clarkson KS, Sturdgess IC, Molyneux AJ. The usefullness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A). J Clin Pathol 2001;54:196-200.
Nybakken GE, Sargen M, Abraham R, Zhang PJ, Ming M, Xu X. MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations. Am J Dermatopathol 2013;35(1):25-9.
Park HY, Yaar M. Biology of melanocytes. Dalam: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Leffel DJ, editors. Fitzpatrick's Dermatology in General Medicine 8th Ed. New York: McGraw Hill Co. 2013. p.792-803.
Girish PN, Shetty NJ, Shetty VH, Sandhya I, Mallya U, Shetty RK, et al. Evaluation of narrow-band UVB phototherapy for vitiligo. Journal of Evolution of Medical and Dental Sciences 2013;2(44):8591-8.
Lotti T, Berti S, moretti S. Vitiligo therapy. Expert Opin. Pharmacother 2009;10(17):2779-85.
Halawi A., Abbas O, Mahalingam M. S100 proteins and the skin: a review. JEADV 2013.1-10.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.